AbbVie Bid for Biotech Could Expand with Experimental Drug
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Analyze which crypto assets deliver real project utility, looking at use cases, partnerships, and on-chain activity to gauge authenticity.
28,337 articlesAbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
Credo Technology Group is at the center of a renewed AI infrastructure rally, with a price prediction: from $269 surf...
Revolut will require new graduates entering its Talent Programmes to come into the office for the majority of the wor...
This week, mortgage rates tick slightly higher but remain near the 6.5% level, according to Freddie Mac. The latest d...
A Palestinian activist has filed a federal lawsuit accusing a network of conservative groups of coordinating to silen...
New labor data reveals a troubling disconnect: participation falls while unemployment headlines stay resilient. Inves...
Authorities say 72 tigers died thai zoos in Chiang Mai from canine distemper, not bird flu, easing human health fears...
Stocks retreat as oil prices jump and volatility returns to markets. The Nasdaq Composite leads losses as investors r...
Datadog stock has slid significantly from its 52-week peak, drawing bargain hunters. This deep dive explains whether ...
Lennar is moving margins from a safeguard role to a circuit-breaker function, prioritizing production throughput as m...
Oil markets jump as tensions with Iran intensify. The IEA warns the iran crisis worst energy shock may strain economi...
Avis Budget Group stock surged this week as travel demand picked up and airport bottlenecks nudged customers toward r...